Drug Costs Should Be Factored Into Insurance Risk Adjustments, Manufacturers Tell CMS
Executive Summary
In recent comments, pharma companies argue to CMS that including drug use in the Affordable Care Act risk adjustment program for individual and small group insurance plans would help discourage discriminatory pricing. Insurers say it would more accurately reflect plan costs.